Search Results
464 items found for "protease-activated receptors (PARs)"
- Community guidelines for GPCR ligand bias: IUPHAR review 32
August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third Depending on which ligand activates a receptor, it can engage different intracellular transducers. 'biased signalling' paradigm requires that we now characterize physiological signalling not just by receptors but by ligand-receptor pairs. The guidelines will aid consistency and clarity, as the basic receptor research and drug discovery communities
- 📰 GPCR Weekly News, March 13 to 19, 2023
GPCR Activation and Signaling Components of TOR and MAP kinase signaling control chemotropism and pathogenicity New paradigms in purinergic receptor ligand discovery. G protein-coupled receptor pharmacology - insights from mass spectrometry. activation. Structural basis for motilin and erythromycin recognition by motilin receptor.
- 📰 GPCR Weekly News
GPCR Activation and Signaling Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances Golgi-compartmentalized Gβγ signaling: mechanisms, functions, and therapeutic targets Constitutive activity colorectal carcinoma in mice Methods & Updates in GPCR Research Middle-Down Mass Spectrometry Reveals Activity-Modifying Phosphorylation Barcode in a Class C G Protein-Coupled Receptor Reviews, GPCRs, and more Life, death Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology.
- 📰 GPCR Weekly News, August 28 to September 3, 2023
GPCR Activation and Signaling Cell death signaling in Anopheles gambiae initiated by Bacillus thuringiensis , and Taste Cholecystokinin-A Signaling Regulates Automaticity of Pacemaker Cardiomyocytes Dopamine Receptor D1 Is Exempt from Transforming Growth Factor β-Mediated Antifibrotic G Protein-Coupled Receptor Landscape A case for (mutant) G protein-coupled receptors Reviews, GPCRs, and more RGS2 and female common diseases receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis Structural
- 📰 GPCR Weekly News, June 12 to 18, 2023
GPCR Activation and Signaling Single transmembrane GPCR modulating proteins: neither single nor simple A unique melanocortin-4-receptor signaling profile for obesity-associated constitutively active variants GPCRs in Neuroscience Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells.
- 📰 GPCR Weekly News, April 17 to 23, 2023
GPCR Symposium on GPCR Activation and Signaling, May 19th, 2023. GPCR Activation and Signaling How can we improve the measurement of receptor signaling bias? The relaxin receptor RXFP1 signals through a mechanism of autoinhibition. Regulation of the pro-inflammatory G protein-coupled receptor GPR84. GPCRs in Neuroscience G protein coupled receptors as targets for transformative neuropsychiatric therapeutics
- 📰 GPCR Weekly News, April 8 to 14, 2024
Sexton et al. for their job on Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP 8th to 14th, 2024 Adhesion GPCRs High incidence of imperforate vagina in ADGRA3-deficient mice GPCR Activation and Signaling Local anesthetics inhibit muscarinic acetylcholine receptor-mediated calcium responses and the consequences on G protein signalling Melanin-concentrating hormone receptor 1 is discarded by in next-generation medicines G protein-coupled receptors (GPCRs): advances in structures, mechanisms
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A2A Adenosine Receptor "Modulators of the G protein-coupled A2A adenosine receptor (A2AAR) have been considered promising agents Structural analysis revealed that the introduced thiophene modification restricted receptor conformational rearrangements required for subsequent activation. This approach can expand the repertoire of adenosine receptor antagonists that can be designed based
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Principles of Pharmacology I Dates: October 3, 10, 17, 24 (four sessions) Topics: Pharmacologic activity Receptors for New Therapeutic Options 📍 Boston, MA 📅 October 2 -3, 2024 Join leading scientists to Nxera Pharma’s Partner Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor Coupled Receptor G1 (ADGRG1/GPR56) promotes pressure overload-induced heart failure GPCR Activation axis signal pathway Structural and Molecular Insights into GPCR Function Exploring the constitutive activation
- 📰 GPCR Weekly News, April 1 to 7, 2024
for their research on Intracellular pocket conformations, determine signaling through the μ opioid receptor Let’s dive into the Classified GPCR News from April 1st to 7th, 2024 GPCR Activation and Signaling GPRASP1 loss-of-function links to arteriovenous malformations by endothelial activating GPR4 signals Mechano-sensitivity of β2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse GPCR Binders, Drugs, and more Predicting associations between drugs and G protein-coupled receptors
- RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα
liver disease (NAFLD) have yet to be fully delineated and only a single drug, peroxisome proliferator-activated receptor (PPAR) α/γ agonist saroglitazar, has been approved. Here, we sought to investigate the role of Regulator of G Protein Signaling 7 (RGS7) in hyperlipidemia-dependent
- VAMP2: a crucial player in the delivery of MOR to the synapse
Transporting Protein-coupled receptors (GPCRs) to the synapse, where they are involved in neurotransmission controlling the trafficking of the receptor to the cell surface. receptor (MOR) [1,6,7]. Trafficking of G protein coupled receptors. Circ. Res. 99:570–582. Jurado, S., D. Goswami, Y. Phosphorylation state of muopioid receptor determines the alternative recycling of receptor via Rab4
- Production of human A2AAR in lipid nanodiscs for 19F-NMR and single-molecule fluorescence...
October 2022 "We describe production of the human A2A adenosine receptor (A2AAR), a class A G protein-coupled receptor (GPCR) for 19F-NMR and single-molecule fluorescence (SMF) spectroscopy. Protocols for SMF experiments include sample setup, data acquisition, data processing, and error analysis
- 📰 GPCR Weekly News, August 21 to 27, 2023
Hébert and their colleagues research on 'G Protein-Biased Agonists for Intracellular Angiotensin Receptors GPCR Activation and Signaling G Protein-Biased Agonists for Intracellular Angiotensin Receptors Promote Collagen Secretion in Myofibroblasts β-arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor GPCR Binders, Drugs, and more Altered G-Protein Transduction Protein receptors relevant to schizophrenia Re-routing GPR56 signaling using Gα12/13 G protein chimeras GPCRs
- 📰 GPCR Weekly News, July 10 to 16, 2023
GPCR Symposium on Structural and Molecular Insights on GPCR Activation! GPCR Activation and Signaling Bias comes in layers. GPCRs in Oncology and Immunology Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates Coupled Receptors. Reviews, GPCRs, and more Optical approaches for investigating neuromodulation and G Protein-Coupled Receptor
- Phosphorylation of RGS regulates MAP kinase localization and promotes completion of cytokinesis
September 2022 "Yeast use the G-protein–coupled receptor signaling pathway to detect and track the mating The G-protein–coupled receptor pathway is inhibited by the regulator of G-protein signaling (RGS) Sst2 which induces Gα GTPase activity and inactivation of downstream signaling. G-protein signaling activates the MAPK Fus3, which phosphorylates the RGS; however, the role of this Completion of cytokinesis in the presence of pheromone is promoted by the kelch-repeat protein, Kel1
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases "The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies, in particular autoimmune diseases. It is activated by the three chemokine ligands CXCL9, CXCL10, and CXCL11 and enables the recruitment
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
highlighted the most significant pathways associated with depression treatment, including neuroactive ligand-receptor analysis indicated that the mechanism of KXS in treating depression was involved in the biological process In conclusion, this study preliminarily revealed key active components in KXS, including Gomisin B, Asarone Pachymic acid, could interact with multiple targets (5-HTR, DR, ADRA, AR, ESR, NR3C1) and modulate the activation of multiple pathways (Neuroactive ligand -receptor interaction pathway, serotonergic synapse pathway
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
receptor (GPCR) structures, especially when experimental data were limited. cellular environment which are crucial for understanding how drugs can selectively target different receptor To fully understand GPCR behavior and optimize drug targeting across multiple receptor states, experimental Ligand discovery from a dopamine D3 receptor homology model and crystal structure. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor
- Isoform-and ligand-specific modulation of adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder
September 2022 "Adhesion G protein-coupled receptors (aGPCRs) are cell-surface proteins with large extracellular Modulating a single function of a specific aGPCR isoform while affecting no other function and no other receptor
- 📰 GPCR Weekly News, April 22 to 28, 2024
receptor latrophilin 1 (ADGRL1/LPHN1) increases the risk of obesity GPCR Activation and Signaling Variable Receptor Inflammatory Signaling at the Endosome GPCR Binders, Drugs, and more Discovery and development of macrocyclic peptide modulators of the cannabinoid 2 receptor GPCRs in Cardiology, Endocrinology, vitro studies GPCRs in Neuroscience Phytocannabinoids in neuromodulation: from omics to epigenetics The receptor receptors Structural and Molecular Insights into GPCR Function Fungal alkaloid malbrancheamide reorients
- Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet
Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinetic studies "G protein-coupled receptors (GPCRs) are an important receptor superfamily and common therapeutic targets. As well, it has not been reported whether the effects of temperature on biosensor activity are reversible optimization studies were carried out using HEK293H cells transiently transfected with the adenosine receptor -22F biosensor had a superior signal-to-background ratio and the effect of temperature on biosensor activity
- Regulation of rod photoreceptor function by farnesylated G-protein γ-subunits
September 2022 "Heterotrimeric G-protein transducin, Gt, is a key signal transducer and amplifier in The only other farnesylated G-protein γ-subunit, Gγ11 (Gng11), is expressed in multiple tissues but not Thus, while farnesylated Gγ subunits are functionally active and largely interchangeable in supporting
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
of GPCR dimerization can have profound effects on GPCR activation, signaling, and intracellular trafficking Somatostatin receptors (SSTs) are class A GPCRs abundantly expressed in pituitary tumors where they represent The cytoskeletal protein filamin A (FLNA) directly interacts with both somatostatin receptor type 2 ( On the contrary, in M2 cells, octreotide failed to internalize both receptors whereas pasireotide promoted robust receptor internalization at shorter times than in A7 cells.
- 📰 GPCR Weekly News, November 13 to 19, 2023
Adhesion GPCRs CryoEM structures of adhesion in GPCR CD97: Filling in some of the gaps GPCR Activation and Signaling Butyrate induces STAT3/HIF-1α/IL-22 signaling via GPCR and HDAC3 inhibition to activate Endosomal signaling via cAMP in parathyroid hormone (PTH) type 1 receptor biology β-arrestin1 is an E3 negatively modulates substance P responses by forming complex with Neurokinin-1 receptor NTR-1's Essential Coupled Receptor Drug Discovery Orion’s VP Drug Discovery, Dr.
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor from the Dendroaspis angusticeps venom is the most selective antagonist of the arginine-vasopressin V2 receptor (V2R) and the only unique Kunitz-type peptide active on a GPCR. MQs form a new subgroup in the Kunitz family, close to the V2R non-active dendrotoxins and to two V2R-active Sequence comparison between active and non-active V2R Kunitz peptides highlighted five positions, among
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
forming a vicious cycle with IGF1/IGF1R signaling pathway "There is a potential correlation between G-protein-coupled receptor-associated sorting protein 1 (GASP1) and breast tumorigenesis. Mechanistically, GASP1 inhibited proteasomal degradation of insulin-like growth factor 1 receptor (IGF1R ) by competitively binding to IGF1R with ubiquitin E3 ligase MDM2, thereby activating its downstream IGF1, in turn, stimulated GASP1 expression by activating the PI3K/AKT pathway, forming a vicious cycle
- Roles of Focal Adhesion Kinase PTK2 and Integrin αIIbβ3 Signaling in Collagen- and GPVI-Dependent...
GPVI-Dependent Thrombus Formation under Shear "Glycoprotein (GP)VI and integrin αIIbβ3 are key signaling receptors kinase 2, PTK2), the shear-dependent collagen receptor GPR56 (ADGRG1 gene), and calcium and integrin-binding protein 1 (CIB1). The suppressive rather than activating effects of pGRP were confined to blood flow at a high shear rate This work thereby supports the role of PTK2 in integrin αIIbβ3 activation and signaling."